Atrás
Rango del Día
$8.28
$8.70
Rango de 52 Semanas
$7.48
$31.18
Volumen
2,285,970
Promedio 50D / 200D
$11.31
/
$13.04
Cierre Anterior
$8.74
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -1.2 | 0.3 |
| P/B | 17.1 | 2.9 |
| ROE % | -310.8 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 5.4 | 0.2 |
Precio Objetivo de Analistas
Hold
$21.29
+153.8%
Low: $10.00
High: $42.00
EPS Futuro
-$2.98
Ingresos Est.
2.5 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.26
$0.05 – $0.72
|
780 M | 4 |
| FY2029 |
-$1.47
-$4.13 – -$0.30
|
330 M | 4 |
| FY2028 |
-$2.25
-$4.07 – -$0.10
|
110 M | 11 |
Puntos Clave
Debt/Equity of 5.36 — high leverage
Negative free cash flow of -610.15M
PEG of 0.06 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-310.75%
ROIC-168.93%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
5.36
Current Ratio3.18
Interest Coverage0.00
Valoración
P/E Ratio
-1.20
P/B Ratio17.06
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -738.82M |
| ROE | -310.75% | ROA | -163.66% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -610.15M |
| ROIC | -168.93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 5.36 | Current Ratio | 3.18 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -1.20 | P/B Ratio | 17.06 |
| P/S Ratio | N/A | PEG Ratio | 0.06 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 888.21M | Enterprise Value | 937.11M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -738.82M | -846.42M | -408.17M | -570.28M | -213.80M |
| EPS (Diluted) | -6.86 | -9.28 | -5.73 | -12.75 | -5.97 |
| Gross Profit | -4.14M | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -745.38M | -885.11M | -436.05M | -567.93M | -218.90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 451.45M | 615.11M | 513.21M | 661.78M | 142.06M |
| Total Liabilities | 399.38M | 191.67M | 85.24M | 123.01M | 47.37M |
| Shareholders' Equity | 52.07M | 423.44M | 427.98M | 538.77M | 34.69M |
| Total Debt | 278.86M | 36.58M | 30.88M | 33.60M | 3.24M |
| Cash & Equivalents | 229.96M | 99.13M | 248.40M | 204.88M | 76.06M |
| Current Assets | 368.33M | 538.47M | 442.45M | 586.97M | 94.82M |
| Current Liabilities | 115.93M | 154.23M | 55.42M | 90.02M | 41.94M |